Equitable Trust’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-16,692
| Closed | -$908K | – | 391 |
|
|
2022
Q2 | $908K | Buy |
16,692
+526
| +3% | +$28.6K | 0.07% | 188 |
|
|
2022
Q1 | $881K | Buy |
16,166
+233
| +1% | +$12.7K | 0.06% | 188 |
|
|
2021
Q4 | $878K | Buy |
15,933
+1,223
| +8% | +$67.4K | 0.05% | 189 |
|
|
2021
Q3 | $703K | Buy |
14,710
+2,149
| +17% | +$103K | 0.04% | 205 |
|
|
2021
Q2 | $625K | Buy |
12,561
+2,179
| +21% | +$108K | 0.04% | 226 |
|
|
2021
Q1 | $463K | Buy |
10,382
+4,075
| +65% | +$182K | 0.03% | 253 |
|
|
2020
Q4 | $290K | Buy |
6,307
+256
| +4% | +$11.8K | 0.02% | 297 |
|
|
2020
Q3 | $284K | Sell |
6,051
-6,487
| -52% | -$304K | 0.02% | 281 |
|
|
2020
Q2 | $639K | Buy |
12,538
+578
| +5% | +$29.5K | 0.06% | 196 |
|
|
2020
Q1 | $567K | Buy |
11,960
+8,443
| +240% | +$400K | 0.06% | 195 |
|
|
2019
Q4 | $206K | Buy |
+3,517
| New | +$206K | 0.02% | 275 |
|